Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - estradiolum, norethisteroni acetas - comprimés pelliculés - a) filmtablette blau: estradiolum 2 mg pour obtenir estradiolum hemihydricum, color.: e 132, excipiens pro compresso de la brume. b) filmtablette retour: estradiolum 2 mg pour obtenir estradiolum hemihydricum, norethisteroni acetas 1 mg, excipiens pro compresso de la brume. c) filmtablette rot: estradiolum 1 mg pour obtenir estradiolum hemihydricum, excipiens pro compresso de la brume. - les œstrogènes-progestatif traitement de substitution en cas de symptômes de la ménopause plaintes - synthetika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - comprimés - semaglutidum 3 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum k 90, magnesii stearas, pro compresso. - le diabète sucré de type 2 - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - comprimés - semaglutidum 7 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum k 90, magnesii stearas, pro compresso. - le diabète sucré de type 2 - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - comprimés - semaglutidum 14 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum k 90, magnesii stearas, pro compresso. - le diabète sucré de type 2 - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - solution injectable en stylo prérempli - semaglutidum 0.25 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - solution injectable en stylo prérempli - semaglutidum 0.5 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - solution injectable en stylo prérempli - semaglutidum 1 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - solution injectable en stylo prérempli - semaglutidum 1.7 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 0.11785 mmol. - gewichtsregulierung - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - solution injectable en stylo prérempli - semaglutidum 2.4 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 0.11785 mmol. - gewichtsregulierung - biotechnologika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - insulinum degludecum, liraglutidum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète de l'adulte - biotechnologika